Description: Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.
Home Page: www.jxr-fertility.com
No. 301, North Jingsha Road
Chengdu,
China
Phone:
86 40 0042 6868
Officers
| Name | Title |
|---|---|
| Mr. Yang Dong | Co-CEO & Exec. Director |
| Ms. Rong Lyu | CO-CEO & Exec. Director |
| Ms. Fei You | Chief Financial Officer |
| Ms. Hongkun Liu | Chief Investment Officer |
| Dr. Ling Chi | Chief Scientific Officer |
| Ms. Pu Shi | VP and Head of human resources & administration |
| Dr. John G. Wilcox | Exec. Director |
| Mr. Yong Zeng | Sr. VP |
| Dr. Lihong Geng | Chief Medical Quality Control Officer & Exec. Director |
| Dr. Yuan Li | Chief Medical Officer |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 20.8768 |
|---|---|
| Trailing PE: | 46.355 |
| Price-to-Book MRQ: | 1.4172 |
| Price-to-Sales TTM: | 1.5178 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2637 |